Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,192 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase Ib trial of lenalidomide as post-remission therapy for older adults with acute myeloid leukemia: Safety and longitudinal assessment of geriatric functional domains.
Woods JD, Zeidner JF, Van Deventer HW, Jamieson K, Matson M, Zhang J, Pulley W, Brenizer T, Muss H, Nyrop KA, Vohra SN, Deal AM, Ivanova A, Foster MC. Woods JD, et al. Among authors: ivanova a. J Geriatr Oncol. 2022 May;13(4):499-504. doi: 10.1016/j.jgo.2021.11.015. Epub 2021 Dec 23. J Geriatr Oncol. 2022. PMID: 34955443 Free PMC article. Clinical Trial.
Phase 1 trial of the proteasome inhibitor bortezomib and pegylated liposomal doxorubicin in patients with advanced hematologic malignancies.
Orlowski RZ, Voorhees PM, Garcia RA, Hall MD, Kudrik FJ, Allred T, Johri AR, Jones PE, Ivanova A, Van Deventer HW, Gabriel DA, Shea TC, Mitchell BS, Adams J, Esseltine DL, Trehu EG, Green M, Lehman MJ, Natoli S, Collins JM, Lindley CM, Dees EC. Orlowski RZ, et al. Among authors: ivanova a. Blood. 2005 Apr 15;105(8):3058-65. doi: 10.1182/blood-2004-07-2911. Epub 2004 Dec 30. Blood. 2005. PMID: 15626743 Free article. Clinical Trial.
A phase I dose-escalation study of clofarabine in combination with fractionated gemtuzumab ozogamicin in patients with refractory or relapsed acute myeloid leukemia.
Foster MC, Amin C, Voorhees PM, van Deventer HW, Richards KL, Ivanova A, Whitman J, Chiu WM, Barr ND, Shea T. Foster MC, et al. Among authors: ivanova a. Leuk Lymphoma. 2012 Jul;53(7):1331-7. doi: 10.3109/10428194.2011.647313. Epub 2012 Jan 31. Leuk Lymphoma. 2012. PMID: 22149206 Clinical Trial.
Two-stage design for phase II oncology trials with relaxed futility stopping.
Ivanova A, Deal AM. Ivanova A, et al. Stat Interface. 2016;9(1):93-98. doi: 10.4310/SII.2016.v9.n1.a9. Epub 2015 Oct 22. Stat Interface. 2016. PMID: 29805727 Free PMC article.
We describe a two-stage design for a single-arm phase II trial where the primary objective is to test the rate of tumor response defined as complete plus partial response, and the secondary objective is to estimate the rate of disease control defined as tumor respon …
We describe a two-stage design for a single-arm phase II trial where the primary objective is to test the rate of tumor respon …
Evaluation of a Test Dose Strategy for Pharmacokinetically-Guided Busulfan Dosing for Hematopoietic Stem Cell Transplantation.
Davis JM, Ivanova A, Chung Y, Shaw JR, Rao KV, Ptachcinski JR, Sharf AA, Serody JS, Armistead PM, Wood WA, Coghill JM, Jamieson KJ, Vincent BG, Riches ML, Shea TC, Alexander MD. Davis JM, et al. Among authors: ivanova a. Biol Blood Marrow Transplant. 2019 Feb;25(2):391-397. doi: 10.1016/j.bbmt.2018.09.017. Epub 2018 Sep 19. Biol Blood Marrow Transplant. 2019. PMID: 30244102 Free article.
1,192 results